Kevin Aholt
About Kevin Aholt
Kevin Aholt serves as the National Account Director at Neurelis, Inc. since 2018, bringing extensive experience in healthcare management and payer-related issues from various leadership roles in prominent organizations.
Work at Neurelis
Kevin Aholt has been serving as the National Account Director at Neurelis, Inc. since 2018. In this role, he is responsible for managing national accounts and developing strategies to enhance brand access. His experience in the pharmaceutical industry contributes to his effectiveness in navigating complex payer landscapes and establishing strong partnerships.
Previous Experience in the Pharmaceutical Industry
Prior to his current position, Aholt held various roles in the pharmaceutical sector. He worked at PCS Health Systems as Director from 1995 to 2000, and at UCB as National Account Executive from 2006 to 2010, followed by Area Director, Market Access & Pricing West from 2010 to 2015. He also served as National Account Manager at ARIES PHARMACEUTICALS from 2017 to 2018 and held positions at CVS Caremark and Grifols Therapeutics.
Education and Expertise
Kevin Aholt studied at St. Louis College of Pharmacy, where he earned his degree in Pharmacy from 1977 to 1982. He possesses deep knowledge in payer-related issues, contracting, formulary management, and distribution within the US healthcare system. His expertise includes building profitable brand access through Group Purchasing Organizations (GPOs), Accountable Care Organizations (ACOs), and Exchanges.
Background in Healthcare Management
Aholt's career includes significant experience in healthcare management. He worked at King Faisal Specialist Hospital and Research Centre in Saudi Arabia as Manager of Inpatient Services from 1984 to 1991. His background also includes roles in pharmacy operations management at Caremark, where he served as Pharmacy Operations Manager from 1991 to 1995.
Crisis Management Experience
Kevin Aholt has demonstrated success in leading organizations through crisis situations in both US and international settings. His ability to navigate challenges in the healthcare landscape has been a key aspect of his career, contributing to his reputation as a capable leader in the pharmaceutical industry.